Product Images Losartan Potassium

The text provides data on a clinical study involving Atenolol and Losartan Potassium as treatment options. The study analyzed the adjusted risk reduction for the primary endpoint and found that 9% of patients experienced improvement. The adjusted risk reduction for Losartan Potassium was 13%, with a p-value of 0.021. The text also displays a chart showing the study month and the number of participants at each month.*

This text provides information on the effects of Losartan Potassium tablets compared to a placebo in reducing the risk of ventricular tachycardia (VT) events in patients. The text indicates that Losartan Potassium tablets resulted in a 16.1% risk reduction compared to the placebo. The p-value for this result was 0.022. The text also displays a table with percentages corresponding to time intervals of 12, 24, and 48. It is unclear what these percentages represent, but it is possible that they are related to the incidence of VT events over time.*

This is a package label for Losartan Potassium Tabs USP 50mg manufactured by Cadila for Zydus. The lot number is 7959 and the expiry date is not specified. The package contains 30 tablets and is stored at temperatures between 20°- 25°C (68° 77° F). The package should be protected from light and dispensed in a tight, light-resistant container. Dosage information can be found on the package insert or label. The rest of the text includes various lot numbers and expiration dates for the same product.*

The text seems to be a collection of codes, markings, and labels related to Losartan Potassium tablets with a strength of 50 mg manufactured by Vanguard Labs in Glasgow KY 42141. The tablets come in packs of tens, and the labeling includes various lot numbers and expiration dates. It also mentions the NDC number and storage instructions. However, there is no other useful information available.*

This is a label of Losartan Potassium Tabs with lot number 7958, having the strength of 25 mg. The medication should be stored at a temperature of 20-25°C (68-77°F), and kept away from light. The packaging has been done by Vangard, Glasgow. The label highlights that the medicine should only be used for institutional use, and users should refer to the package insert or label for dosage instructions. Few other lot numbers for Losartan Potassium tabs and their manufacturing details have also been mentioned. There is no other pertinent information available from this label.*

This is a medication package containing Losartan Potassium tabs USP 100 mg, manufactured by Cadila for Zydus. The package includes the lot number, expiration date, Rx-only, and NDC information. The medication should be stored at controlled room temperature and should be kept in a tight, light-resistant container to protect from light. The package insert or label should be referred for proper dosage information. The package also includes the trademark of Omnicare, Inc. This is for institutional use only.*